HomeCompareOBMP vs MO

OBMP vs MO: Dividend Comparison 2026

OBMP yields 128.21% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OBMP wins by $11.51M in total portfolio value
10 years
OBMP
OBMP
● Live price
128.21%
Share price
$1.56
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11.60M
Annual income
$4,575,129.27
Full OBMP calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — OBMP vs MO

📍 OBMP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOBMPMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OBMP + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OBMP pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OBMP
Annual income on $10K today (after 15% tax)
$10,897.44/yr
After 10yr DRIP, annual income (after tax)
$3,888,859.88/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, OBMP beats the other by $3,863,224.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OBMP + MO for your $10,000?

OBMP: 50%MO: 50%
100% MO50/50100% OBMP
Portfolio after 10yr
$5.84M
Annual income
$2,302,644.21/yr
Blended yield
39.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

OBMP
No analyst data
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OBMP buys
0
MO buys
0
No recent congressional trades found for OBMP or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOBMPMO
Forward yield128.21%6.36%
Annual dividend / share$2.00$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6%
Portfolio after 10y$11.60M$80.1K
Annual income after 10y$4,575,129.27$30,159.17
Total dividends collected$10.60M$74.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: OBMP vs MO ($10,000, DRIP)

YearOBMP PortfolioOBMP Income/yrMO PortfolioMO Income/yrGap
1← crossover$23,521$12,820.51$10,570$780.30+$13.0KOBMP
2$53,349$28,181.78$11,381$1,032.90+$42.0KOBMP
3$116,823$59,739.54$12,535$1,392.73+$104.3KOBMP
4$247,259$122,259.11$14,193$1,920.91+$233.1KOBMP
5$506,405$241,837.18$16,618$2,723.68+$489.8KOBMP
6$1,004,750$462,896.88$20,263$3,993.80+$984.5KOBMP
7$1,933,425$858,342.70$25,936$6,098.36+$1.91MOBMP
8$3,612,406$1,543,641.03$35,166$9,775.01+$3.58MOBMP
9$6,560,727$2,695,452.74$51,026$16,597.78+$6.51MOBMP
10$11,595,107$4,575,129.27$80,113$30,159.17+$11.51MOBMP

OBMP vs MO: Complete Analysis 2026

OBMPStock

Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. The company through its patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. The company's data-generating assays provide actionable information for physicians, patients, and biopharmaceutical companies in the area of oncology. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. The company is headquartered in Golden, Colorado.

Full OBMP Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this OBMP vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OBMP vs SCHDOBMP vs JEPIOBMP vs OOBMP vs KOOBMP vs MAINOBMP vs PMOBMP vs BTIOBMP vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.